ANELLODESIGN
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jun 2025)
What this means for you
This application is over — abandoned 16 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97269150
- Mark type
- Stylized text
- Filed
- 16 Feb 2022
- Published for opposition
- 21 Mar 2023
- Abandoned
- 16 Jun 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anellovirsues; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development
- Class 042 — Scientific and technological services: Product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of anelloviruses; laboratory services for the discovery, capture, and analysis of data in the field of anelloviruses; providing online non-downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic product
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jan 2025 — SOU EXTENSION 3 GRANTED
- 14 Nov 2024 — SOU EXTENSION 3 FILED
- 30 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 2 GRANTED
- 14 May 2024 — SOU EXTENSION 2 FILED
- 14 May 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED